Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UiPath SEC filings document material events for an enterprise automation software company listed under PATH. Recent Form 8-K disclosures cover operating and financial results, executive leadership and compensation arrangements, annual meeting voting outcomes, and governance matters including director elections, advisory compensation votes, and auditor ratification.
The filings also record capital-structure subjects tied to UiPath's Class A and Class B common stock, including stockholder trading-plan disclosures. These records frame PATH's public-company reporting around results releases, board and officer matters, stockholder votes, and equity ownership structure.
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/16/2025, the officer sold a total of 10,000 Class A shares in two trades executed under a pre‑arranged Rule 10b5-1 plan.
The first sale was 8,300 shares at a weighted average price of $16.2211 (price range $15.8100–$16.7700). The second was 1,700 shares at a weighted average price of $16.9918 (range $16.8100–$17.4900). Following these transactions, the officer beneficially owns 222,776 shares, held directly.
UiPath (PATH) filed a Form 144 notice for a proposed sale of 10,000 common shares with an aggregate market value of $166,900. The filing lists Morgan Stanley Smith Barney LLC as broker, an approximate sale date of 10/16/2025, and trading on the NYSE. The shares were acquired via restricted stock units from the issuer on 01/01/2024. Shares outstanding were 453,568,899.
The filing also reports recent Rule 10b5-1 sales for Hitesh Ramani: 10,000 shares on 10/13/2025 for $170,056, 10,000 on 10/14/2025 for $165,351, and 10,000 on 10/15/2025 for $166,801.
UiPath (PATH) reported an insider transaction by its GC & Chief Legal Officer, Brad Brubaker. On 10/15/2025, he sold 27,580 shares of Class A common stock in an open-market transaction executed under a Rule 10b5-1 trading plan.
The reported average price was $16.6761, with trades occurring in a range from $16.2100 to $17.2000. Following the sale, Brubaker beneficially owns 662,939 shares, held directly.
UiPath (PATH) CEO Daniel Dines reported an insider sale. A Form 4 shows the sale of 122,734 shares of Class A common stock on 10/15/2025, executed pursuant to a Rule 10b5-1 trading plan.
The filing lists a price of $16.9245 and notes trades occurred within a range of $16.7200 to $17.0600. Footnotes indicate certain shares are held through Ice Vulcan Holding Limited, with Mr. Dines retaining sole voting and investment power through affiliated entities. He is identified as Director, CEO and Chairman, and a 10% Owner.
UiPath (PATH) filed a Form 4 reporting that its Chief Accounting Officer sold Class A common stock pursuant to a Rule 10b5-1 plan. The officer sold 10,000 shares on 10/14/2025 at an average price of $16.5351 (price range $16.1200–$16.9000) and 10,000 shares on 10/15/2025 at an average price of $16.6801 (price range $16.2400–$17.1100).
Following these transactions, the reporting person beneficially owned 232,776 shares, held directly.
UiPath (PATH) filed a Form 144 notice for a proposed sale of restricted securities by an affiliate. The filing lists 10,000 common shares to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $164,800, on or about 10/15/2025 on the NYSE. Shares outstanding were 453,568,899.
The shares were acquired as Restricted Stock Units from the issuer on 01/01/2024. The notice also reports recent activity under a 10b5-1 framework: on 10/14/2025, 10,000 shares sold for $165,351, and on 10/13/2025, 10,000 shares sold for $170,056.
UiPath (PATH) insider BRAD C BRUBAKER filed a Form 144 notice to sell company stock. The filing lists 27,580 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $454,518.40. The approximate sale date is 10/15/2025, and the shares trade on the NYSE.
The shares to be sold were acquired on 07/01/2023 via restricted stock units. As context, shares outstanding were 453,568,899. The notice also lists recent plan-driven sales: 66,665 shares on 10/06/2025 for $999,985.58 and 16,083 shares on 09/30/2025 for $241,262.69, each under a Rule 10b5-1 trading plan.
Form 144 is a notice of proposed sales by an affiliate and does not itself execute the transaction.
UiPath (PATH) COO & CFO Ashim Gupta reported insider transactions on 10/09/2025. He exercised 148,009 stock options at $0.7533 per share and executed open‑market sales under a Rule 10b5‑1 trading plan.
Sales were reported in three blocks: 181,745 shares at an average price of $17.0122 (range $16.2800–$17.2700), 32,144 shares at $17.7403 (range $17.2800–$18.2700), and 26,985 shares at $18.5263 (range $18.2800–$18.7300). Following these transactions, he directly owned 696,117 Class A shares.
UiPath (PATH) CEO and Chairman Daniel Dines reported open‑market sales under a Rule 10b5‑1 plan. He sold 122,734 Class A shares on 10/13/2025 at an average price of $17.0604 (price range $16.8700–$17.2900) and 122,734 shares on 10/14/2025 at an average price of $16.3347 (range $16.0700–$16.8100).
Following these transactions, reported holdings include 245,468 Class A shares held indirectly via Ice Vulcan Holding Limited, 29,918,585 Class A shares held directly, and 240,000 Class A shares held indirectly by spouse.
UiPath (PATH) disclosed a Form 4 showing its Chief Accounting Officer sold 10,000 shares of Class A common stock on 10/13/2025 at an average price of $17.0056 under a Rule 10b5-1 trading plan.
Following the sale, the officer directly owned 252,776 shares. The reported trades occurred within a price range of $16.6400 to $17.3400.